Compare ALLE & EHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALLE | EHC |
|---|---|---|
| Founded | 2013 | 1983 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Hospital/Nursing Management |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9B | 12.4B |
| IPO Year | N/A | 1986 |
| Metric | ALLE | EHC |
|---|---|---|
| Price | $161.45 | $99.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $170.33 | $142.86 |
| AVG Volume (30 Days) | 804.4K | ★ 1.0M |
| Earning Date | 02-17-2026 | 02-05-2026 |
| Dividend Yield | ★ 1.26% | 0.74% |
| EPS Growth | 13.70 | ★ 27.89 |
| EPS | ★ 7.39 | 5.29 |
| Revenue | $3,979,700,000.00 | ★ $5,795,600,000.00 |
| Revenue This Year | $10.07 | $11.54 |
| Revenue Next Year | $6.55 | $8.76 |
| P/E Ratio | $21.85 | ★ $19.43 |
| Revenue Growth | 6.87 | ★ 11.13 |
| 52 Week Low | $116.57 | $90.67 |
| 52 Week High | $180.68 | $127.99 |
| Indicator | ALLE | EHC |
|---|---|---|
| Relative Strength Index (RSI) | 50.14 | 21.92 |
| Support Level | $157.81 | $103.58 |
| Resistance Level | $166.79 | $108.47 |
| Average True Range (ATR) | 3.01 | 2.02 |
| MACD | 0.34 | -0.35 |
| Stochastic Oscillator | 45.66 | 18.56 |
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.